Peptide self-assembly: From toxins to amyloid fibrils and nanotubes

Current Topics in Medicinal Chemistry

Volumn 14, Issue 6, 2014, Pages 740-746

  Rawat, Anoop ^a   Nagaraj, Ramakrishnan ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Amyloids; A ; Nanostructures; Peptide channels; Peptide self assembly; Peptide toxins; Peptides

Indexed keywords

ALAMETHICIN; AMYLOID; AMYLOID BETA PROTEIN; GRAMICIDIN A; MELITTIN; NANOTUBE; OLIGOMER; TOXIN;

CHANNEL GATING; HUMAN; PHYSICAL CHEMISTRY; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN SELF ASSEMBLY; REVIEW; X RAY DIFFRACTION;

AMYLOID; NANOTUBES; PEPTIDES; TOXINS, BIOLOGICAL;

EID: 84896361220     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026614666140118221120     Document Type: Review

References (140)

1. Killian, J.A. Gramicidin and gramicidin-lipid interactions. Biochim. Biophys. Acta, 1992, 1113, 391-425.
2. Roux, B. Computational studies of the gramicidin channel. Acc. Chem. Res., 2002, 35, 366-375.
3. Andersen, O.S.; Koeppe, R.E., 2nd; Roux, B. Gramicidin channels. IEEE Trans. Nanobioscience, 2005, 4, 10-20.
4. Kelkar, D.A.; Chattopadhyay, A. The gramicidin ion channel: a model membrane protein. Biochim. Biophys. Acta, 2007, 1768, 2011-2025.
5. Nagaraj, R.; Balaram, P. Alamethicin, a transmembrane channel. Acc. Chem. Res., 1981, 14, 356-362.
6. Sansom, M.S. The biophysics of peptide models of ion channels. Prog. Biophys. Mol. Biol., 1991, 55, 139-235.
7. Leitgeb, B.; Szekeres, A.; Manczinger, L.; Vágvölgyi, C.; Kredics, L. The history of alamethicin: a review of the most extensively studied peptaibol. Chem. Biodivers., 2007, 4, 1027-1051.
8. Cafiso, D.S. Alamethicin: a peptide model for voltage gating and protein-membrane interactions. Annu. Rev. Biophys. Biomol. Struct., 1994, 23, 141-165.
9. Pieta, P.; Mirza, J.; Lipkowski, J. Direct visualization of the alamethicin pore formed in a planar phospholipid matrix. Proc. Natl. Acad. Sci. U.S.A., 2012, 109, 21223-21227.
10. Futaki, S.; Noshiro, D.; Kiwada, T.; Asami, K. Extramembrane Control of Ion Channel Peptide Assemblies, Using Alamethicin as an Example. Acc. Chem. Res., 2013, [Epub ahead of print] DOI: 10.1021/ar400051f.
11. Dempsey, C.E. The actions of melittin on membranes. Biochim. Biophys. Acta, 1990, 1031, 143-161.
12. Raghuraman, H.; Chattopadhyay, A. Melittin: a membrane-active peptide with diverse functions. Biosci. Rep., 2007, 27, 189-223.
13. Lee, M.-T.; Sun, T.-L.; Hung, W.-C.; Huang, H.W. Process of inducing pores in membranes by melittin. Proc. Natl. Acad. Sci. U.S.A., 2013, 110, 14243-14248.
14. Gajski, G.; Garaj-Vrhovac, V. Melittin: A lytic peptide with anticancer properties. Environ. Toxicol. Pharmacol., 2013, 36, 697-705.
15. Huang, C.; Jin, H.; Qian, Y.; Qi, S.; Luo, H.; Luo, Q.; Zhang, Z. Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo. ACS Nano, 2013, 7, 5791-5800.
16. Chiti, F.; Dobson, C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem., 2006, 75, 333-366.
17. Dobson, C.M. Protein folding and misfolding. Nature, 2003, 426, 884-890.
18. Eichner, T.; Radford, S.E. A diversity of assembly mechanisms of a generic amyloid fold. Mol. Cell, 2011, 43, 8-18.
19. Dumoulina, M.; Bader, R. A short historical survey of developments in amyloid research. Protein Pept. Lett., 2006, 13, 213-217.
20. Naiki, H.; Higuchi, K.; Hosokawa, M.; Takeda, T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem., 1989, 177, 244-249.
21. LeVine, H., 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci., 1993, 2, 404-410.
22. Sunde, M.; Serpell, L.C.; Bartlam, M.; Fraser, P.E.; Pepys, M.B.; and Blake, C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol., 1997, 273, 729-739.
23. Nelson, R.; Eisenberg, D. Structural models of amyloid-like fibrils. Adv. Protein Chem., 2006, 73, 235-282.
24. Stefani, M.; Dobson, C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med., 2003, 81, 678-699.
25. Fowler, D.M.; Koulov, A.V.; Balch, W.E.; and Kelly, J.W. Functional amyloid--from bacteria to humans. Trends Biochem. Sci., 2007, 32, 217-224.
26. Sawaya, M.R.; Sambashivan, S.; Nelson, R.; Ivanova, M.I.; Sievers, S.A.; Apostol, M.I.; Thompson, M.J.; Balbirnie, M.; Wiltzius, J.J.W.; McFarlane, H.T.; Madsen, A.Ø.; Riekel, C.; Eisenberg, D. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature, 2007, 447, 453-457.
27. Tycko, R.; Wickner, R.B. Molecular structures of amyloid and prion fibrils: consensus versus controversy. Acc. Chem. Res., 2013, 46, 1487-1496.
28. Wogulis, M.; Wright, S.; Cunningham, D.; Chilcote, T.; Powell, K.; Rydel, R.E. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J. Neurosci., 2005, 25, 1071-1080.
29. Lee, J.; Culyba, E.K.; Powers, E.T.; and Kelly, J.W. Amyloid-β forms fibrils by nucleated conformational conversion of oligomers. Nat. Chem. Biol., 2011, 7, 602-609.
30. Caughey, B.; Lansbury, P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci., 2003, 26, 267-298.
31. Benilova, I.; Karran, E.; De Strooper, B. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci., 2012, 15, 349-357.
32. Lashuel, H.A.; Hartley, D.; Petre, B.M.; Walz, T.; Lansbury, P.T., Jr. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature, 2002, 418, 291.
33. Kayed, R.; Head, E.; Thompson, J.L.; McIntire, T.M.; Milton, S.C.; Cotman, C.W.; Glabe, C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 2003, 300, 486-489.
34. Butterfield, S.M.; Lashuel, H.A. Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew. Chem. Int. Ed. Engl., 2010, 49, 5628-5654.
35. Chiti, F.; Webster, P.; Taddei, N.; Clark, A.; Stefani, M.; Ramponi, G.; Dobson, C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 3590-3594.
36. Dobson, C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci., 1999, 24, 329-332.
37. Rauk, A. The chemistry of Alzheimer's disease. Chem. Soc. Rev., 2009, 38, 2698-2715.
38. Kedar, I.; Ravid, M.; Sohar, E. In vitro synthesis of "amyloid" fibrils from insulin, calcitonin and parathormone. Isr. J. Med. Sci., 1976, 12, 1137-1140.
39. Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature, 1999, 399, A23-31.
40. Glenner, G.G.; Wong, C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun., 1984, 120, 885-890.
41. Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002, 297, 353-356.
42. Fukuda, H.; Shimizu, T.; Nakajima, M.; Mori, H.; Shirasawa, T. Synthesis, aggregation, and neurotoxicity of the Alzheimer's Abeta1-42 amyloid peptide and its isoaspartyl isomers. Bioorg. Med. Chem. Lett., 1999, 9, 953-956.
43. Sharpe, S.; Yau, W.-M.; Tycko, R. Expression and purification of a recombinant peptide from the Alzheimer's b-amyloid protein for solid-state NMR. Protein Expr. Purif., 2005, 42, 200-210.
44. Kirschner, D.A.; Inouye, H.; Duffy, L.K.; Sinclair, A.; Lind, M.; Selkoe, D.J. Synthetic peptide homologous to b protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. U.S.A., 1987, 84, 6953-6957.
45. Jarrett, J.T.; Berger, E.P.; Lansbury, P.T., Jr. The carboxy terminus of the b amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry, 1993, 32, 4693-4697.
46. Snyder, S.W.; Ladror, U.S.; Wade, W.S.; Wang, G.T.; Barrett, L.W.; Matayoshi, E.D.; Huffaker, H.J.; Krafft, G.A.; Holzman, T.F. Amyloid-b aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J., 1994, 67, 1216-1228.
47. Klein, A.M.; Kowall, N.W.; Ferrante, R.J. Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex. Ann. N. Y. Acad. Sci., 1999, 893, 314-320.
48. Kuperstein, I.; Broersen, K.; Benilova, I.; Rozenski, J.; Jonckheere, W.; Debulpaep, M.; Vandersteen, A.; Segers-Nolten, I.; Van Der Werf, K.; Subramaniam, V.; Braeken, D.; Callewaert, G.; Bartic, C.; D'Hooge, R.; Martins, I.C.; Rousseau, F.; Schymkowitz, J.; De Strooper, B. Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J., 2010, 29, 3408-3420.
49. Kodali, R.; Wetzel, R. Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. Struct. Biol., 2007, 17, 48-57.
50. Walsh, D.M.; Klyubin, I.; Fadeeva, J.V.; Cullen, W.K.; Anwyl, R.; Wolfe, M.S.; Rowan, M.J.; Selkoe, D.J. Naturally secreted oligomers of amyloid b protein potently inhibit hippocampal longterm potentiation in vivo. Nature, 2002, 416, 535-539.
51. Hoshi, M.; Sato, M.; Matsumoto, S.; Noguchi, A.; Yasutake, K.; Yoshida, N.; Sato, K. Spherical aggregates of b-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3b. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 6370-6375.
52. Reed, M.N.; Hofmeister, J.J.; Jungbauer, L.; Welzel, A.T.; Yu, C.; Sherman, M.A.; Lesné, S.; LaDu, M.J.; Walsh, D.M.; Ashe, K.H.; Cleary, J.P. Cognitive effects of cell-derived and synthetically derived Aβoligomers. Neurobiol. Aging, 2011, 32, 1784-1794.
53. Lambert, M.P.; Barlow, A.K.; Chromy, B.A.; Edwards, C.; Freed, R.; Liosatos, M.; Morgan, T.E.; Rozovsky, I.; Trommer, B.; Viola, K.L.; Wals, P.; Zhang, C.; Finch, C.E.; Krafft, G.A.; Klein, W.L. Diffusible, nonfibrillar ligands derived from Ab1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A., 1998, 95, 6448-6453.
54. Lasagna-Reeves, C.A.; Glabe, C.G.; Kayed, R. Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain. J. Biol. Chem., 2011, 286, 22122-22130.
55. Fraser, P.E.; Nguyen, J.T.; Inouye, H.; Surewicz, W.K.; Selkoe, D.J.; Podlisny, M.B.; Kirschner, D.A. Fibril formation by primate, rodent, and Dutchhemorrhagic analogues of Alzheimer amyloid bprotein. Biochemistry, 1992, 31, 10716-10723.
56. Burdick, D.; Soreghan, B.; Kwon, M.; Kosmoski, J.; Knauer, M.; Henschen, A.; Yates, J.; Cotman, C.; Glabe, C. Assembly and aggregation properties of synthetic Alzheimer's A4/b amyloid peptide analogs. J. Biol. Chem., 1992, 267, 546-554.
57. Fraser, P.E.; McLachlan, D.R.; Surewicz, W.K.; Mizzen, C.A.; Snow, A.D.; Nguyen, J.T.; Kirschner, D.A. Conformation and fibrillogenesis of Alzheimer Ab peptides with selected substitution of charged residues. J. Mol. Biol., 1994, 244, 64-73.
58. De Groot, N.S.; Aviles, F.X.; Vendrell, J.; Ventura, S. Mutagenesis of the central hydrophobic cluster in Ab42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities. FEBS J., 2006, 273, 658-668.
59. Ovchinnikova, O.Y.; Finder, V.H.; Vodopivec, I.; Nitsch, R.M.; Glockshuber, R. The Osaka FAD mutation E22β leads to the formation of a previously unknown type of amyloidβ fibrils and modulates Aβ neurotoxicity. J. Mol. Biol., 2011, 408, 780-791.
60. Armstrong, A.H.; Chen, J.; McKoy, A.F.; Hecht, M.H. Mutations that replace aromatic side chains promote aggregation of the Alzheimer's Aβ peptide. Biochemistry, 2011, 50, 4058-4067.
61. Cukalevski, R.; Boland, B.; Frohm, B.; Thulin, E.; Walsh, D.; Linse, S. Role of aromatic side chains in amyloid β-protein aggregation. ACS Chem. Neurosci., 2012, 3, 1008-1016.
62. Tõugu, V.; Tiiman, A.; Palumaa, P. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-b peptide. Metal ion binding, contribution to fibrillization and toxicity. Metallomics, 2011, 3, 250-261.
63. Chen, W.-T.; Liao, Y.-H.; Yu, H.-M.; Cheng, I.H.; Chen, Y.-R. Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-b destabilization promotes annular protofibril formation. J. Biol. Chem., 2011, 286, 9646-9656.
64. Simmons, L.K.; May, P.C.; Tomaselli, K.J.; Rydel, R.E.; Fuson, K.S.; Brigham, E.F.; Wright, S.; Lieberburg, I.; Becker, G.W.; Brems, D.N. Secondary structure of amyloid b peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol., 1994, 45, 373-379.
65. Howlett, D.R.; Jennings, K.H.; Lee, D.C.; Clark, M.S.; Brown, F.; Wetzel, R.; Wood, S.J.; Camilleri, P.; Roberts, G.W. Aggregation state and neurotoxic properties of Alzheimer b-amyloid peptide. Neurodegeneration, 1995, 4, 23-32.
66. Teplow, D.B. Preparation of amyloid b-protein for structural and functional studies. Meth. Enzymol., 2006, 413, 20-33.
67. Wood, S.J.; Maleeff, B.; Hart, T.; Wetzel, R. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Ab. J. Mol. Biol., 1996, 256, 870-877.
68. Jao, S.-C.; Ma, K.; Talafous, J.; Orlando, R.; Zagorski, M. G. Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide. Amyloid, 1997, 4, 240-252.
69. Fezoui, Y.; Hartley, D.M.; Harper, J.D.; Khurana, R.; Walsh, D.M.; Condron, M.M.; Selkoe, D.J.; Lansbury, P.T., Jr; Fink, A.L.; Teplow, D.B. An improved method of preparing the amyloid bprotein for fibrillogenesis and neurotoxicity experiments. Amyloid, 2000, 7, 166-178.
70. Manzoni, C.; Colombo, L.; Messa, M.; Cagnotto, A.; Cantù, L.; Del Favero, E.; Salmona, M. Overcoming synthetic Ab peptide aging: a new approach to an age-old problem. Amyloid, 2009, 16, 71-80.
71. Selkoe, D.J. Cell biology of the amyloid b-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol., 1994, 10, 373-403.
72. Soreghan, B.; Kosmoski, J.; Glabe, C. Surfactant properties of Alzheimer's Ab peptides and the mechanism of amyloid aggregation. J. Biol. Chem., 1994, 269, 28551-28554.
73. Sabaté, R.; Estelrich, J. Evidence of the existence of micelles in the fibrillogenesis of b-amyloid peptide. J. Phys. Chem. B, 2005, 109, 11027-11032.
74. Urbanc, B.; Betnel, M.; Cruz, L.; Bitan, G.; Teplow, D.B. Elucidation of amyloid b-protein oligomerization mechanisms: discrete molecular dynamics study. J. Am. Chem. Soc., 2010, 132, 4266-4280.
75. Mager, P.P. Molecular simulation of the primary and secondary structures of the Abβ (1-42)-peptide of Alzheimer's disease. Med. Res. Rev., 1998, 18, 403-430.
76. Yang, M.; Teplow, D.B. Amyloid b-protein monomer folding: freeenergy surfaces reveal alloform-specific differences. J. Mol. Biol., 2008, 384, 450-464.
77. Garvey, M.; Morgado, I. Peptide concentration alters intermediate species in amyloid β fibrillation kinetics. Biochem. Biophys. Res. Commun., 2013, 433, 276-280.
78. Kusumoto, Y.; Lomakin, A.; Teplow, D.B.; Benedek, G.B. Temperature dependence of amyloid b-protein fibrillization. Proc. Natl. Acad. Sci. U.S.A., 1998, 95, 12277-12282.
79. Filippov, A.V., Göbner, G.; Antzutkin, O.N. Aggregation of amyloid Abβ (1-40) peptide in perdeuterated 2,2,2-trifluoroethanol caused by ultrasound sonication. Magn. Reson. Chem., 2010, 48, 427-434.
80. Harper, J.D.; Lieber, C.M.; Lansbury, P.T., Jr. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-b protein. Chem. Biol., 1997, 4, 951-959.
81. Paravastu, A.K.; Leapman, R.D.; Yau, W.-M.; Tycko, R. Molecular structural basis for polymorphism in Alzheimer's b-amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A., 2008, 105, 18349-18354.
82. Margittai, M.; Langen, R. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys., 2008, 41, 265-297.
83. Meinhardt, J.; Sachse, C.; Hortschansky, P.; Grigorieff, N.; Fändrich, M. Abβ (1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J. Mol. Biol., 2009, 386, 869-877.
84. Khurana, R.; Uversky, V.N.; Nielsen, L.; Fink, A.L. Is Congo red an amyloid-specific dye? J. Biol. Chem., 2001, 276, 22715-22721.
85. Hua, Q.; Weiss, M.A. Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a proteinfolding intermediate. J. Biol. Chem., 2004, 279, 21449-21460.
86. De Jong, K.L.; Incledon, B.; Yip, C.M.; DeFelippis, M.R. Amyloid fibrils of glucagon characterized by high-resolution atomic force microscopy. Biophys. J., 2006, 91, 1905-1914.
87. Arvinte, T.; Cudd, A.; Drake, A.F. The structure and mechanism of formation of human calcitonin fibrils. J. Biol. Chem., 1993, 268, 6415-6422.
88. Andreotti, G.; Motta, A. Modulating calcitonin fibrillogenesis: an antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin. J. Biol. Chem., 2004, 279, 6364-6370.
89. Morozova-Roche, L.A.; Zurdo, J.; Spencer, A.; Noppe, W.; Receveur, V.; Archer, D.B.; Joniau, M.; Dobson, C.M Amyloid fibril formation and seeding by wild-type human lysozyme and its disease- related mutational variants. J. Struct. Biol., 2000, 130, 339-351.
90. Shankar, G.M.; Li, S.; Mehta, T.H.; Garcia-Munoz, A.; Shepardson, N.E.; Smith, I.; Brett, F.M.; Farrell, M.A.; Rowan, M.J.; Lemere, C.A.; Regan, C.M.; Walsh, D.M.; Sabatini, B.L.; Selkoe, D.J. Amyloid- b protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med., 2008, 14, 837-842.
91. Hung, L.W.; Ciccotosto, G.D.; Giannakis, E.; Tew, D.J.; Perez, K.; Masters, C.L.; Cappai, R.; Wade, J.D.; Barnha, K.J. Amyloid- b peptide (Abβ) neurotoxicity is modulated by the rate of peptide aggregation: Ab dimers and trimers correlate with neurotoxicity. J. Neurosci., 2008, 28, 11950-11958.
92. Finder, V.H.; Vodopivec, I.; Nitsch, R.M.; and Glockshuber, R. The recombinant amyloid-b peptide Ab1-42 aggregates faster and is more neurotoxic than synthetic Abβ 1-42. J. Mol. Biol., 2010, 396, 9-18.
93. Ahmed, M.; Davis, J.; Aucoin, D.; Sato, T.; Ahuja, S.; Aimoto, S.; Elliott, J.I.; Van Nostrand, WE.; Smith, S.O. Structural conversion of neurotoxic amyloid-b(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol., 2010, 17, 561-567.
94. Chimon, S.; Shaibat, M.A.; Jones, C.R.; Calero, D.C.; Aizezi, B.; Ishii, Y. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid. Nat. Struct. Mol. Biol., 2007, 14, 1157-1164.
95. Findeis, M.A. Peptide inhibitors of b amyloid aggregation. Curr. Top. Med. Chem., 2002, 2, 417-423.
96. Sciarretta, K.L.; Gordon, D.J.; Meredith, S.C. Peptide-based inhibitors of amyloid assembly. Meth. Enzymol., 2006, 413, 273-312.
97. Härd, T.; Lendel, C. Inhibition of amyloid formation. J. Mol. Biol., 2012, 421, 441-465.
98. Yamamoto, S.; Hasegawa, K.; Yamaguchi, I.; Tsutsumi, S.; Kardos, J.; Goto, Y.; Gejyo, F.; Naiki, H. Low concentrations of sodium dodecyl sulfate induce the extension of b 2-microglobulinrelated amyloid fibrils at a neutral pH. Biochemistry, 2004, 43, 11075-11082.
99. Rangachari, V.; Moore, B.D.; Reed, D.K.; Sonoda, L.K.; Bridges, A.W.; Conboy, E.; Hartigan, D.; Rosenberry, T.L. Amyloid-b(1- 42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate. Biochemistry, 2007, 46, 12451-12462.
100. Tjernberg, L.; Hosia, W.; Bark, N.; Thyberg, J.; Johansson, J. Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides. J. Biol. Chem., 2002, 277, 43243-43246.
101. Goux, W.J.; Kopplin, L.; Nguyen, A.D.; Leak, K.; Rutkofsky, M.; Shanmuganandam, V.D.; Sharma, D.; Inouye, H.; Kirschner, D.A. The formation of straight and twisted filaments from short tau peptides. J. Biol. Chem., 2004, 279, 26868-26875.
102. Jones, S.; Manning, J.; Kad, N.M.; Radford, S.E. Amyloid-forming peptides from bβ 2-microglobulin-Insights into the mechanism of fibril formation in vitro. J. Mol. Biol., 2003, 325, 249-257.
103. De La Paz López, M.;Goldie, K.; Zurdo, J.; Lacroix, E.; Dobson, C.M.; Hoenger, A.; Serrano, L. De novo designed peptide-based amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A, 2002, 99, 16052-16057.
104. Liu, C.; Zhao, M.; Jiang, L.; Cheng, P.-N.; Park, J.; Sawaya, M.R.; Pensalfini, A.; Gou, D.; Berk, A.J.; Glabe, C.G.; Nowick, J.; Eisenberg, D. Out-of-register _-sheets suggest a pathway to toxic amy loid aggregates. Proc. Natl. Acad. Sci. U.S.A, 2012, 109, 20913-20918.
105. Balbach, J.J.; Ishii, Y.; Antzutkin, O.N.; Leapman, R.D.; Rizzo, N.W.; Dyda, F.; Reed, J.; Tycko, R. Amyloid fibril formation by Ab16-22, a seven-residue fragment of the Alzheimer's b-amyloid peptide, and structural characterization by solid state NMR. Biochemistry, 2000, 39, 13748-13759.
106. Krysmann, M.J.; Castelletto, V.; Hamley, I.W. Fibrillisation of hydrophobically modified amyloid peptide fragments in an organic solvent. Soft Matter, 2007, 3, 1401-1406.
107. Senguen, F.T.; Lee, N.R.; Gu, X.; Ryan, D.M.; Doran, T.M.; Anderson, E.A.; Nilsson, B.L. Probing aromatic, hydrophobic, and steric effects on the self-assembly of an amyloid-β fragment peptide. Mol. Biosyst., 2011, 7, 486-496.
108. Senguen, F.T.; Doran, T.M.; Anderson, E.A.; Nilsson, B.L. Clarifying the influence of core amino acid hydrophobicity, secondary structure propensity, and molecular volume on amyloid-β 16-22 self-assembly. Mol. Biosyst., 2011, 7, 497-510.
109. Inouye, H.; Gleason, K.A.; Zhang, D.; Decatur, S.M.; Kirschner, D.A. Differential effects of Phe19 and Phe20 on fibril formation by amyloidogenic peptide Ab16-22 (Ac-KLVFFAE-NH2). Proteins, 2010, 78, 2306-2321.
110. Tao, K.; Wang, J.; Zhou, P.; Wang, C.; Xu, H.; Zhao, X.; Lu, J.R. Self-Assembly of Short Aβ (16-22) Peptides: Effect of Terminal Capping and the Role of Electrostatic Interaction. Langmuir, 2011, 27, 2723-2730.
111. Chaudhary, N.; Nagaraj, R. Impact on the replacement of Phe by Trp in a short fragment of Aβ amyloid peptide on the formation of fibrils. J. Pept. Sci., 2011, 17, 115-123.
112. Chaudhary, N.; Singh, S.; Nagaraj, R. Organic solvent mediated self-association of an amyloid forming peptide from b2- microglobulin: an atomic force microscopy study. Biopolymers, 2008, 90, 783-791.
113. Chaudhary, N.; Singh, S.; Nagaraj, R. Morphology of selfassembled structures formed by short peptides from the amyloidogenic protein tau depends on the solvent in which the peptides are dissolved. J. Pept. Sci., 2009, 15, 675-684.
114. Lashuel, H.A.; Hartley, D.M.; Petre, B.M.; Wall, J.S.; Simon, M.N.; Walz, T.; Lansbury, P.T., Jr. Mixtures of wild-type and a pathogenic (E22G) form of Ab40 in vitro accumulate protofibrils, including amyloid pores. J. Mol. Biol., 2003, 332, 795-808.
115. Pachahara, S.K.; Chaudhary, N.; Subbalakshmi, C.; Nagaraj, R. Hexafluoroisopropanol induces self-assembly of β-amyloid peptides into highly ordered nanostructures. J. Pept. Sci., 2012, 18, 233-241.
116. Fernandez-Escamilla, A.-M.; Rousseau, F.; Schymkowitz, J.; Serrano, L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol., 2004, 22, 1302-1306.
117. Gordon, D.J.; Balbach, J.J.; Tycko, R.; Meredith, S.C. Increasing the amphiphilicity of an amyloidogenic peptide changes the b-sheet structure in the fibrils from antiparallel to parallel. Biophys. J., 2004, 86, 428-434.
118. Qahwash, I.M.; Boire, A.; Lanning, J.; Krausz, T.; Pytel, P.; Meredith, S.C. Site-specific effects of peptide lipidation on b-amyloid aggregation and cytotoxicity. J. Biol. Chem., 2007, 282, 36987-36997.
119. Rawat, A.; Nagaraj, R. Covalently attached fatty acyl chains alter the aggregation behavior of an amyloidogenic peptide derived from humn b2-microglobulin. J. Pept. Sci., 2013, (in press).
120. Deng, M.; Yu, D.; Hou, Y.; Wang, Y. Self-assembly of peptideamphiphile C12-Ab(11-17) into nanofibrils. J. Phys. Chem. B, 2009, 113, 8539-8544.
121. Hamada, D.; Yanagihara, I.; Tsumoto, K. Engineering amyloidogenicity towards the development of nanofibrillar materials. Trends Biotechnol., 2004, 22, 93-97.
122. Cherny, I.; Gazit, E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed. Engl., 2008, 47, 4062-4069.
123. Krysmann, M.J.; Castelletto, V.; Kelarakis, A.; Hamley, I.W; Hule, R.A.; Pochan, D.J. Self-assembly and hydrogelation of an amyloid peptide fragment. Biochemistry, 2008, 47, 4597-4605.
124. Lu, K.; Jacob, J.; Thiyagarajan, P.; Conticello, V.P.; Lynn, D.G. Exploiting amyloid fibril lamination for nanotube self-assembly. J. Am. Chem. Soc., 2003, 125, 6391-6393.
125. Krysmann, M.J.; Castelletto, V.; McKendrick, J.E.; Clifton, L.A.; W Hamley, I.; Harris, P.J.F.; King, S.M. Self-assembly of Peptide nanotubes in an organic solvent. Langmuir, 2008, 24, 8158-8162.
126. Reches, M.; Gazit, E. Casting metal nanowires within discrete selfassembled peptide nanotubes. Science, 2003, 300, 625-627.
127. Amdursky, N.; Molotskii, M.; Gazit, E.; Rosenman, G. Elementary building blocks of self-assembled peptide nanotubes. J. Am. Chem. Soc., 2010, 132, 15632-15636.
128. Subbalakshmi, C.; Manorama, S.V.; Nagaraj, R. Self-assembly of short peptides composed of only aliphatic amino acids and a combination of aromatic and aliphatic amino acids. J. Pept. Sci., 2012, 18, 283-292.
129. Orbach, R.; Adler-Abramovich, L.; Zigerson, S.; Mironi-Harpaz, I.; Seliktar, D.; Gazit, E. Self-assembled Fmoc-peptides as a platform for the formation of nanostructures and hydrogels. Biomacromolecules, 2009, 10, 2646-2651.
130. Jayawarna, V.; Ali, M.; Jowitt, T.A.; Miller, A.F.; Saiani, A.; Gough, J.E.; Ulijn, R.V. Nanostructured Hydrogels for Three- Dimensional Cell Culture Through Self-Assembly of Fluorenylmethoxycarbonyl- Dipeptides. Adv. Mater., 2006, 18, 611-614.
131. Mahler, A.; Reches, M.; Rechter, M.; Cohen, S.; Gazit, E. Rigid, Self-Assembled Hydrogel Composed of a Modified Aromatic Dipeptide. Adv. Mater., 2006, 18, 1365-1370.
132. De Groot, N.S.; Parella, T.; Aviles, F.X.; Vendrell, J.; Ventura, S. Ile-phe dipeptide self-assembly: clues to amyloid formation. Biophys. J., 2007, 92, 1732-1741.
133. Cheng, G.; Castelletto, V.; Moulton, C.M.; Newby, G.E.; Hamley, I.W. Hydrogelation and self-assembly of Fmoc-tripeptides: unexpected influence of sequence on self-assembled fibril structure, and hydrogel modulus and anisotropy. Langmuir, 2010, 26, 4990-4998.
134. Cui, H.; Muraoka, T.; Cheetham, A.G.; Stupp, S.I. Self-assembly of giant peptide nanobelts. Nano Lett., 2009, 9, 945-951.
135. Reches, M.; Gazit, E. Formation of closed-cage nanostructures by self-assembly of aromatic dipeptides. Nano Lett., 2004, 4, 581-585.
136. Khoe, U.; Yang, Y.; Zhang, S. Self-assembly of nanodonut structure from a cone-shaped designer lipid-like peptide surfactant. Langmuir, 2009, 25, 4111-4114.
137. Castelletto, V.; Hamley, I.W.; Harris, P.J.F.; Olsson, U.; Spencer, N. Influence of the solvent on the self-assembly of a modified amyloid peptide fragment. I. Morphological investigation. J. Phys. Chem. B, 2009, 113, 9978-9987.
138. Görbitz, C.H. Microporous organic materials from hydrophobic dipeptides. Chemistry, 2007, 13, 1022-1031.
139. Kol, N.; Adler-Abramovich, L.; Barlam, D.; Shneck, R.Z.; Gazit, E.; Rousso, I. Self-assembled peptide nanotubes are uniquely rigid bioinspired supramolecular structures. Nano Lett., 2005, 5, 1343-1346.
140. Mart, R.J.; Osborne, R.D.; Stevens, M.M.; Ulijn, R.V. Peptidebased stimuli-responsive biomaterials. Soft Matter, 2006, 2, 822-835.